LabCorp introduced Xcellerate COVID-19 clinical study solution
On Jun. 29, 2020, LabCorp announced that Covance, its drug development business, has deployed the Xcellerate COVID-19 solution…
-
-
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
-
U.S. Dept of Veterans Affairs launched COVID-19 screening tool
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
-
Oxford University dashboard highlighted potential future COVID-19 virus hotspots
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
-
Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
-
Association between statewide school closure and COVID-19 incidence and mortality in the US
On Jun. 29, 2020, a study published in JAMA showed that in the U.S., states enacted nonpharmaceutical interventions,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
-
Altimmune received award from US DoD to fund phase 1/2 clinical trial of T-COVID in outpatients with early COVID-19
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
-
Experts identifed steps to expand and improve antibody tests in COVID-19 response
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
-
Biotechnology | COVID-19 | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine has been selected to participate in a…
-
CIRM board approved third clinical trial for COVID-19
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
-
University of Alberta researcher to test whether COVID-19 antibodies provide long-term immunity
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
-
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
-
Moderna and Catalent announced collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
-
LabCorp launched new neutralizing antibody test
On Jun. 25, 2020, LabCorp announced the launch of a new test that can be used to assess…
-
RedHill Biopharma announced data from severe COVID-19 patients showed substantial benefit to patients
On Jun. 24, 2020, RedHill Biopharma announced that results from the treatment of the first severe COVID-19 patients…
-
Why men may fare worse than women against SARS-CoV-2
On Jun. 24, 2020, Howard Hughes Medical Institute (HHMI) investigators reported that data from COVID-19 cases around the…
-
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
-
New Oxford University co-led platform accelerated COVID-19 tests into real-world use
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
-
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
-
Experts identified steps to expand and improve antibody tests in COVID-19 response
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
-
FibroGen announced first patient enrolled in Pamrevlumab clinical trial in patients hospitalized in US with acute COVID-19
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
-
Mateon selected IQVIA for its randomized, controlled, multi-menter clinical study to test OT-101 as treatment for COVID-19 patients
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
-
Taconic Biosciences announced distribution of critical COVID-19 mouse model
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
-
The NIH halted clinical trial of hydroxychloroquine
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Vaccine
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals began clinical trials
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
-
COVID-19 pandemic dramatically increased out-of-hospital cardiac arrest cases and deaths in New York City
On Jun. 19, 2020, The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
